164 related articles for article (PubMed ID: 20232719)
21. A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.
Worthington MA; El-Mallakh RS
J Clin Psychopharmacol; 2015 Apr; 35(2):192-3. PubMed ID: 25587693
[No Abstract] [Full Text] [Related]
22. Asenapine-Induced Acute Dystonia in an Adolescent Male.
Bhuyan D; Ghosh S; Bhattacharya A; Praharaj SK
J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):955-956. PubMed ID: 27154343
[TBL] [Abstract][Full Text] [Related]
23. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
[TBL] [Abstract][Full Text] [Related]
24. A Review of Asenapine in the Treatment of Bipolar Disorder.
Vieta E; Montes JM
Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
[TBL] [Abstract][Full Text] [Related]
25. Lumateperone: First Approval.
Blair HA
Drugs; 2020 Mar; 80(4):417-423. PubMed ID: 32060882
[TBL] [Abstract][Full Text] [Related]
26. [Antipsychotic medications for bipolar I disorders. New atypical neuroleptic drug asenapine approved].
Juckel G
Nervenarzt; 2012 Mar; 83(3):384-6. PubMed ID: 22048568
[No Abstract] [Full Text] [Related]
27. Lumateperone: A Novel Antipsychotic for Schizophrenia.
Greenwood J; Acharya RB; Marcellus V; Rey JA
Ann Pharmacother; 2021 Jan; 55(1):98-104. PubMed ID: 32590907
[TBL] [Abstract][Full Text] [Related]
28. Asenapine once daily versus twice daily: impact on patient acceptance in a randomized, open-label, 14-day clinical trial.
Sun X; Hamer R; McEvoy J
J Clin Psychiatry; 2015 Jul; 76(7):992-3. PubMed ID: 26231009
[No Abstract] [Full Text] [Related]
29. Asenapine for the treatment of bipolar disorder.
Marazziti D; Mucci F; Falaschi V; Dell'Osso L
Expert Opin Pharmacother; 2019 Aug; 20(11):1321-1330. PubMed ID: 31132287
[No Abstract] [Full Text] [Related]
30. Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration.
Suzuki H; Hibino H; Inoue Y; Takaya A
Asian J Psychiatr; 2019 Jan; 39():22. PubMed ID: 30472350
[No Abstract] [Full Text] [Related]
31. Common sense.
Prescrire Int; 2012 Oct; 21(131):228. PubMed ID: 23185841
[No Abstract] [Full Text] [Related]
32. Iloperidone, asenapine and lurasidone: a primer on their current status.
Tarazi FI; Stahl SM
Expert Opin Pharmacother; 2012 Sep; 13(13):1911-22. PubMed ID: 22849428
[TBL] [Abstract][Full Text] [Related]
33. Sudden-onset dystonia in a patient taking asenapine: interaction between ciprofloxacin and asenapine metabolism.
Ridout KK; Ridout SJ; Pirnie LF; Puttichanda SP
Am J Psychiatry; 2015 Nov; 172(11):1162-3. PubMed ID: 26575453
[No Abstract] [Full Text] [Related]
34. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
Citrome L
Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903
[TBL] [Abstract][Full Text] [Related]
35. Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.
Findling RL; Landbloom RP; Mackle M; Pallozzi W; Braat S; Hundt C; Wamboldt MZ; Mathews M
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):384-96. PubMed ID: 26091193
[TBL] [Abstract][Full Text] [Related]
36. The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.
Tarazi FI; Neill JC
Expert Opin Drug Discov; 2013 Jan; 8(1):93-103. PubMed ID: 23121334
[TBL] [Abstract][Full Text] [Related]
37. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
[TBL] [Abstract][Full Text] [Related]
38. Asenapine: a clinical overview.
Potkin SG
J Clin Psychiatry; 2011; 72 Suppl 1():14-8. PubMed ID: 22217438
[TBL] [Abstract][Full Text] [Related]
39. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
Stepanova E; Grant B; Findling RL
Paediatr Drugs; 2018 Apr; 20(2):121-134. PubMed ID: 29170943
[TBL] [Abstract][Full Text] [Related]
40. Asenapine: a synthesis of efficacy data in bipolar mania and schizophrenia.
McIntyre RS; Wong R
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):217-20. PubMed ID: 22182459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
